Exosomes are cell-derived nanovesicles carrying growth factors and signaling molecules that can stimulate dermal papilla cells and activate hair follicle stem cells
Eight major RCTs of GLP-1RAs have investigated the cardiovascular outcomes, including the ELIXA trial of lixisenatide (250), the EXSCEL trial of exenatide ER (251), the LEARDER trial of liraglutide (252), the SUSTAIN-6 trial of subcutaneous semaglutide (253), the HARMONY trial of albiglutide (228), the REWIND trial of dulaglutide (254), the PIONEER trial of oral semaglutide (255), and the SELECT trial of subcutaneous semaglutide (199)
[18] [22] In December 2025, an oral version of semaglutide, sold under the brand name Wegovy, was approved in the US for weight management
It is a basic sterility measure that eliminates the most common contamination vector: the bacteria on your skin
There is no magic bullet for obesity
That kind of evidence can show links, but more research including placebo-controlled trials are needed to confirm the findings